Immune checkpoint blockade therapy in head and neck cancer: a review

• Váldodahkkit: Shajedul Islam (Dahkki), Md Shahed Rafi Pavel (Dahkki), Syed Taufiqul Islam (Dahkki), Nazmus Shalehin (Dahkki), Shahed Jahan Babu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Update Dental College, 2018-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Head and neck cancer (HNC) is a common malignant tumor, carrying a poor prognosis, and despite advances in oncology, this rate has not improved significantly for decades. It has recently been evaluated that the immunologic checkpoint inhibitors become a novel promising strategic immunotherapy in the...